GlassScriptPhysician profile
Emily Milliken
NPI 1629565130
$8,928.96
in general payments reported to CMS, 2019-2025
14 companies · $388 in 2025
The $388 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,561 · 2022: $2,610 · 2023: $2,718 · 2024: $653 · 2025: $388.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,445 · Travel and Lodging: $1,313.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,445.24 |
| Travel and Lodging | $1,313.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $7,023.94 | 2021-2023 | Corevalve Evolut R, Linq II |
| Stryker Corporation | $910.05 | 2023-2025 | Gamma, Bio4, Hoffmann |
| Edwards Lifesciences Corporation | $434.29 | 2021-2022 | |
| Integra Lifesciences Corporation | $148.36 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Heron Therapeutics, INC. | $123.63 | 2025 | Zynrelef |
| Janssen Pharmaceuticals, INC | $99.81 | 2021-2022 | |
| Boston Scientific Corporation | $45.36 | 2021-2022 | |
| Chiesi USA, INC. | $30.95 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $28.06 | 2021-2022 | |
| W. L. Gore & Associates, INC. | $21.38 | 2024 | Gore Excluder Aaa Endoprosthesis |
| Alexion Pharmaceuticals, INC. | $18.27 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $17.89 | 2023 | Opsumit |
| Bayer Healthcare Pharmaceuticals INC. | $14.84 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $12.13 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Milliken listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.